# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-25-038046
Filing Date
2025-04-23
Accepted
2025-04-23 16:33:53
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-23

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | tm2512881d1_ars.pdf | ARS | 1106768
| Complete submission text file | 0001104659-25-038046.txt |  | 1518694

Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-33958 | Film No.: 25862064
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)